Adults With Moderate to Severe Asthma

Study identifier:SD-004-0764

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A randomized, blinded, Multicenter, parallel study comparing the efficacy and safety of Pulmicort Respules at 0.5mg QD, 1.0mg QD, 1.0mg bid, 2.0mg bid and Pulmicort Turbuhaler at 4.00mcg bid on Adolescents (12 yrs of age and older) with adults with moderate to severe asthma.

Medical condition

asthma

Phase

Phase 3

Healthy volunteers

No

Study drug

Budesonide

Sex

All

Actual Enrollment

900

Study type

Interventional

Age

12 Years - 150 Years

Date

Study Start Date: 01 Apr 2003
Primary Completion Date: 01 Dec 2004
Study Completion Date: 01 Dec 2004

Study design

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria